期刊文献+

肝移植后免疫抑制药的应用 被引量:2

Application of immunosuppressant after liver transplantation
下载PDF
导出
摘要 目前肝移植取得了迅速的发展,但也面临着一些问题,主要是如何诱导稳定而持久的免疫耐受,以及如何确定和维护已形成的免疫耐受。恰当地选择药物组合,维持适度的免疫抑制状态,减少药物的副作用及相关并发症,切实提高移植患者的生活质量和生存率。文章研究了肝移植后免疫耐受的产生机制,介绍了常见的免疫抑制剂及作用机制,探讨了免疫调节治疗方案及个体化治疗,并展望了免疫调节药物治疗关注的问题。 So far, liver transplantation has made a rapid development, but it also faces some problems. The main problems are how to induce stable and persistent immune tolerance, and how to determine and maintain formed immune tolerance. Selecting the proper drug combination, maintaining the moderate immunosuppressive condition, and decreasing the side reactions and complications induced by drugs can practically improve the life qualities and survival rates of the transplant patients. The article studies the production mechanism of immune tolerance, introduces some common immunosuppressants and their effect mechanisms, investigates treatment protocols of immune regulation and individual treatment, and prospects concerned problems of drug treatment of immune regulation.
作者 吴军
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第18期3495-3498,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献16

  • 1Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell. 1994; 76(2):263-274. 被引量:1
  • 2李鸿,郑树森.肝移植免疫抑制治疗的现状及趋势[J].国际移植与血液净化杂志,2006,4(6):24-27. 被引量:2
  • 3黄雄,伍晓汀.肝移植免疫耐受的研究现状[J].西部医学,2006,18(3):358-360. 被引量:2
  • 4陈辉星,尹路,彭承宏,李宏为.肝移植免疫抑制剂应用及存在问题[J].国际外科学杂志,2006,33(6):407-410. 被引量:5
  • 5Barshes NR, Goodpastor SE, Goss JA. Pharmacologic immunosuppression. Front Biosci. 2004; 9:411-420. 被引量:1
  • 6Barshes NR, Annambhotla S, Bechara C, et al. Endovascular repair of hemodialysis graft-related pseudoaneurysm: an alternative treatment strategy in salvaging failing dialysis access. Vasc Endovascular Surg. 2008; 42(3):228-234. 被引量:1
  • 7丁振斌,徐泱,樊嘉,周俭.肝癌肝移植与免疫抑制剂的应用[J].中国临床医学,2006,13(3):420-422. 被引量:3
  • 8Eason JD, Loss GE, Blazek J, et al. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transpl. 2001; 7(8): 693-697. 被引量:1
  • 9Boillot O, Mayer DA, Boudjema K, et al. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Liver Transpl. 2005; 11(1):61-67. 被引量:1
  • 10Lucey MR, Abdelmalek MF, Gagliardi R, et al. A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant. 2005; 5(5):1111-1119. 被引量:1

二级参考文献59

  • 1ZHOUJian FANJia WUZhi-quan QIUShuang-jian HUANGXiao-wu YUYao WANGZheng SUNJian XIAOYong-sheng HEYi-feng YANGGuo-huan SONGKang YUANZhou WANGYu-qi TANGZhao-you.Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China[J].Chinese Medical Journal,2005(8):654-659. 被引量:26
  • 2樊嘉,徐泱,周俭.肝癌患者肝移植适应证的选择[J].中华医学杂志,2005,85(24):1662-1664. 被引量:23
  • 3Levy G,Burra P,Cavallari A,et al.Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr postdose levels(C2).Transplantation,2002,73:953-959. 被引量:1
  • 4Trotter.JF,Wachs M,Bak T,et al.Liver transplantation using sirolimus and minimal corticosteroids (3 day taper).Liver Transplant,2001,7:343-351. 被引量:1
  • 5European FK506 Multicentre Liver Study Group.Randomised trial comparing tacrolimus(FK506) and cyclosporin in prevention of liver allograft rejection.Lancet,1994,344:423-428. 被引量:1
  • 6The U.S.Multicenter FK506 Liver Study Group.A comparison of tacrolimus(FK506) and cyclosporine for immunosuppvession in liver transplantation.N Engl J Med,1994,331:1110-1115. 被引量:1
  • 7O'Grady JG,Burroughs A,Hardy P,et al.Tacrolimus versus microemulsified ciclosporin in liver transplantation:the TMC randomised controlled trial.Lancet,2002,360:1119-1125. 被引量:1
  • 8Lucey MR,Abdelmalek MF,Gagliardi R,et al.A comparison of tacrolimus and cyclosporine in liver transplantation:effects on renal function and cardiovascular risk status.Am J Transplant,2005,5:1111-1119. 被引量:1
  • 9Takatsuki M,Uemoto S,Inomata Y,et al.Weaning of immunosuppression in living donor liver transplant recipients.Transplantation,2001,72:449-454. 被引量:1
  • 10Tamura S,Sugawara Y,Kishi Y,et al.Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus:a single-center experience at the University of Tokyo.Transplant Proc,2004,36:3242-3244. 被引量:1

共引文献10

同被引文献39

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部